Genetic linkage between atopic IgE responses and chromosome 11q13 (DI1S97) has been previously reported in a limited number of extended families. Difficulties of phenotyping in the older family members, poor family structure in some families, and genetic heterogeneity were proposed as possible explanations for the variability in lod scores. To test this finding a second linkage study of 64 young nuclear families was undertaken and gave a two point lod score of 3-8 at 0 = 0 07 (assuming Om = Of). A test of genetic heterogeneity in the nuclear families shows that atopic IgE responses are linked to this locus in 60 to 100% of families (approximate 95% confidence limits).
Atopy is an allergic disorder that affects over 30% of some western populations' 2 and is the major (but not exclusive) cause of asthma, rhinitis, and eczema in children and young adults.' Atopy is characterised by immunoglobulin E (IgE) responses to environmental proteins which are otherwise innocuous and predominantly found in house dust and plant pollens. 4 confidence limits for a were defined by subtracting one from the maximum lod score.
Results

PHENOTYPING
All families in which complete data on both parents and at least two children were obtained were used for study (63 Caucasian and one West Indian). Children's ages ranged from 1 to 18 years (mean age 8 0 years) with 65 girls and 88 boys. In 43 families one parent was atopic, in 16 both parents were atopic, and in five neither parent was demonstrably atopic. Of the designated atopic subjects (56% of the parents and 75% of children), 91 % of parents and 74% of children were positive for skin prick testing or RAST or both, 77% of parents and 63% of children were positive for two or more criteria, 80% of parents and 78% of children reported symptoms, and 1% of parents and 4% of children were positive on skin testing only. Of the 79% of atopic subjects with symptoms during their life, 57% had asthma, 56% had rhinitis, and 39% had eczema.
TWO POINT LINKAGE ANALYSIS
The maximum lod score was 3 80 at 0 = 0 067 (under the assumption Omale= Ofemale) from 32 informative families giving 46 meioses. However, a test of male/female difference in 0 is significant with estimated Om=0 182 and Of= 0.001 (X2 = 6-44, 1 df, p < 0.02); the test statistic for linkage under this hypothesis is 5-21 on the lod scale. The contributions from the families in which one, both, or neither parents were atopic were + 359, + 0 62, and + 1-00 respectively. The results were not sensitive to changes in penetrances: the maximum lod statistic was 5 50 if penetrance was assumed to be 99% and 4 87 if it was assumed to be 90%.
HETEROGENEITY ANALYSIS
Using the two point data between atopy and XMS.51 in the nuclear families, under the assumption of equal male and female recombination frequencies, the maximum likelihood estimate of the proportion of linked families was cx = 1-0 (no heterogeneity). The approximate 95% confidence region based on a X2 distribution with one degree of freedom extends to a=0 6 (that is, in 60 to 100% of families atopic IgE responsiveness appears to be linked to the llq locus).
Discussion
Our results support the hypothesis that atopic IgE responsiveness (IGER) is linked to chromosome 11 q 13 (combined lod score in nuclear and extended families is in excess of 8). The testing of further families in the presence of incorrect assignment of phenotype, significant genetic heterogeneity, or phenocopies would have reduced rather than added to the lod score. '8 In the present study of young families, phenotyping of atopy was considerably easier because the effects of smoking and old age were reduced. Of the designated atopic subjects, 74% of children and 91% of parents were positive for skin prick testing or RAST or both. A high total IgE was the sole criterion in 9% of parents and 26% of children, a high IgE being highly predictive for the development of atopic disorders (asthma, rhinitis, and eczema) in children.'9 All parents were under the age of 52 years (mean 37-0 years, range 24 to 52) and all of the 9% of parents with a raised total IgE as their only criterion were non-smokers. Positive skin testing was the sole criterion in only 4% of the children and in only 1% of the parents.
In both the nuclear and extended family studies we have consistently found 5 to 10% of atopic subjects have apparently non-atopic parents. This could be the result of phenocopies, incomplete penetrance, or genetic heterogeneity. In the five nuclear families from this study in which neither parent was affected (8% of nuclear families), the lod score contribution was 1-0 (of the total score of 5-2), which supports our model and suggests that a nonpenetrant heterozygote parent may be present in each of these families. The estimated difference in the male/female recombination frequencies is the subject of further analysis.
Though the precise assignment of individual nuclear families with small sibships to an unlinked group has limitations, the heterogeneity analysis has allowed us to define the proportion of families linked to 1 Iq within confidence limits. The 95% confidence interval for a was 60 to 100% in the nuclear families we recruited. We believe the recruitment of more families is necessary to test further for heterogeneity of this immunological phenotype at this locus. However, confirmation of linkage in this study of a larger sample of the atopic population, together with our heterogeneity analysis, suggests the 11 ql3 region contains a major locus conferring atopic IgE responsiveness, the underlying immunological abnormality that characterises the common allergic disorders of atopy.
